The UK Anti-Doping Agency has expressed concern over new findings, which reveal individuals who take supplements lack the knowledge as to what they contain.
The UK’s advertising watchdog has censured Solvotrin Therapeutics for claiming that its Active Iron supplement was better tolerated in nine out of ten people.
There are considerable challenges in gathering scientific data to recommend the use of probiotics and prebiotics in a clinical paediatric setting, but the evidence that exists points to their effectiveness in a number of situations.
Baze has developed a closed-loop personalised nutrition model that uses blood micronutrient analysis and app data to deliver tailored supplements to the doorstep of its consumers.
Aker BioMarine says a recent award recognizing its innovative practices is a validation of the long road toward achieving the scale necessary to engage in category building projects.
Berlin-based startup NOURI wants to expand into the UK supplements market with its line of highly-concentrated stimulant shots that it says shake up a very 'dusty' herbal market.
A meta-analysis published yesterday found slim to no evidence of benefit in lessening cardiovascular disease risk for a range of vitamin and mineral ingredients.
A recently posted warning letter cites a New York company for the presence of an aromatase inhibitor in one of its dietary supplements. This class of chemicals is popular with strength trainers for its purported ability to suppress estrogen levels.
Simultaneously ingesting EPA and DHA may have a positive synergistic effect on exercise performance, but more evidence is needed to confirm this, say researchers in Japan.
The concept of nutrient timing still has a place among the supplements and recovery aids that make up the sports nutrition sector, as an expert believes manufacturers can harness its principles to enhance a product's effectiveness.
HP Ingredients has revealed details of a new European Union (EU) patent granted to its cognitive health ingredient NeuroActin, which has shown efficacy in animal models of Alzheimer’s disease.
The European Food Safety Authority (EFSA) has approved the use of shrimp peptides in food supplements, opening up an opportunity to develop a nutritional approach to blood pressure control.
